藥品參考
Catumaxomab
Catumaxomab is a medicine in the class oncology.
- 藥物類別: Oncology
最後更新 來源: EMA SmPC
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Oncology
- ATC 代碼
- L01FX03
- 商品名
- 1
- 國家與市場
- 1
作用方式
Trifunctional rat-mouse hybrid monoclonal antibody directed against EpCAM and CD3. A third binding site in the Fc region engages accessory immune cells via Fc-gamma receptors. This brings tumour cells, T-cells and accessory immune cells together and induces T-cell activation, T-cell killing, ADCC, CDC and phagocytosis.
成人常用劑量（仿單摘要）
Malignant ascites with EpCAM-positive carcinomas: four intraperitoneal infusions of 10 micrograms on day 0, 20 micrograms on day 3, 50 micrograms on day 7 and 150 micrograms on day 10; overall treatment period should not exceed 21 days
懷孕與哺乳
- 懷孕
- Unknown No or limited human data, and animal studies are insufficient. EU label: not recommended in pregnancy or in women who could become pregnant and are not using contraception.
- 哺乳
- Unknown Unknown whether it passes into milk; a risk to the infant cannot be excluded. EU label: decide whether to stop breastfeeding or the therapy. Given into the abdomen for malignant ascites.
已通報的副作用
- Pyrexia
- Abdominal pain
- Nausea
- Vomiting
- Cytokine release syndrome
- Chills, fatigue, pain, diarrhoea, raised C-reactive protein
禁忌症
- Hypersensitivity to the active substance or to any of the excipients.
- Hypersensitivity to murine (rat and/or mouse) proteins.
哪些人需要特別留意
- Cytokine release symptoms can occur despite premedication, up to grade 4; patients should seek immediate medical attention.
- Systemic inflammatory response syndrome has been reported; patients should seek immediate medical attention if signs occur.
- Administration is not recommended in the presence of acute infections or other factors interfering with the immune system.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
同類別的其他藥品
常見問題
What is Catumaxomab used for?
Catumaxomab is a medicine in the class oncology.
What side effects have been reported with Catumaxomab?
Pyrexia, Abdominal pain, Nausea, Vomiting, Cytokine release syndrome, Chills, fatigue, pain, diarrhoea, raised C-reactive protein.
Can Catumaxomab be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No or limited human data, and animal studies are insufficient. EU label: not recommended in pregnancy or in women who could become pregnant and are not using contraception. Breastfeeding: Unknown. Unknown whether it passes into milk; a risk to the infant cannot be excluded. EU label: decide whether to stop breastfeeding or the therapy. Given into the abdomen for malignant ascites.
What does Catumaxomab interact with?
MediHelp does not list a checked interaction for Catumaxomab yet. Always tell your pharmacist about every medicine you take.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
